Page last updated: 2024-09-03

caprylates and Drug Withdrawal Symptoms

caprylates has been researched along with Drug Withdrawal Symptoms in 2 studies

Research

Studies (2)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	0 (0.00)	18.2507
2000's	2 (100.00)	29.6817
2010's	0 (0.00)	24.3611
2020's	0 (0.00)	2.80

Authors

Authors	Studies
DePierre, JW; Nelson, BD; Xie, Y; Yang, Q	1
DePierre, JW; Eriksson, AM; Nelson, BD; Xie, Y; Yang, Q	1

Other Studies

2 other study(ies) available for caprylates and Drug Withdrawal Symptoms

Article	Year
The relationship between liver peroxisome proliferation and adipose tissue atrophy induced by peroxisome proliferator exposure and withdrawal in mice. Biochemical pharmacology, 2003, Sep-01, Volume: 66, Issue:5 Topics: Adipose Tissue; Animals; Apolipoproteins; Caprylates; Cholesterol; Epidermis; Fatty Acids; Fluorocarbons; Lipids; Lipoprotein Lipase; Liver; Male; Mice; Mice, Inbred C57BL; Mitochondria, Liver; Organ Size; Oxidation-Reduction; Peroxisome Proliferators; Peroxisomes; Substance Withdrawal Syndrome; Time Factors; Triglycerides	2003
Further evidence for the involvement of inhibition of cell proliferation and development in thymic and splenic atrophy induced by the peroxisome proliferator perfluoroctanoic acid in mice. Biochemical pharmacology, 2001, Oct-15, Volume: 62, Issue:8 Topics: Animals; Atrophy; Body Weight; Caprylates; Cell Cycle; Cell Division; Dose-Response Relationship, Drug; Fluorocarbons; Hypertrophy; Liver; Male; Mice; Mice, Inbred C57BL; Models, Animal; Organ Size; Peroxisome Proliferators; Peroxisomes; Phenotype; Spleen; Substance Withdrawal Syndrome; Thymus Gland; Time Factors	2001

Article

Year

The relationship between liver peroxisome proliferation and adipose tissue atrophy induced by peroxisome proliferator exposure and withdrawal in mice.

Biochemical pharmacology, 2003, Sep-01, Volume: 66, Issue:5

Topics: Adipose Tissue; Animals; Apolipoproteins; Caprylates; Cholesterol; Epidermis; Fatty Acids; Fluorocarbons; Lipids; Lipoprotein Lipase; Liver; Male; Mice; Mice, Inbred C57BL; Mitochondria, Liver; Organ Size; Oxidation-Reduction; Peroxisome Proliferators; Peroxisomes; Substance Withdrawal Syndrome; Time Factors; Triglycerides

2003

Further evidence for the involvement of inhibition of cell proliferation and development in thymic and splenic atrophy induced by the peroxisome proliferator perfluoroctanoic acid in mice.

Biochemical pharmacology, 2001, Oct-15, Volume: 62, Issue:8

Topics: Animals; Atrophy; Body Weight; Caprylates; Cell Cycle; Cell Division; Dose-Response Relationship, Drug; Fluorocarbons; Hypertrophy; Liver; Male; Mice; Mice, Inbred C57BL; Models, Animal; Organ Size; Peroxisome Proliferators; Peroxisomes; Phenotype; Spleen; Substance Withdrawal Syndrome; Thymus Gland; Time Factors

2001